Cel-Sci announces reverse stock split

Cel-Sci Corp., of Vienna, Va., and Elkridge, a biotechnology company that is developing new immune system-based treatments for cancer and infectious diseases, announced Friday it is implementing a 1-for-10 reverse stock split, effective on Wednesday.

Leave a Reply

Your email address will not be published. Required fields are marked *